Use of diagnostic imaging for #GCA is ⬆️ Use of temporal artery biopsy⬇️ data from #MayoClinicRheumatology @garveythomasma1 #acr20 #RheumTwitter https://t.co/kQTg5FTlVq

HCQ Not Associated with QTc Length in SLE and RA Patients: Dr. Janet Pope @Janetbirdope #ACR20 https://t.co/zPIaFIiqr5 https://t.co/Wk8YQpIpo7

• https://bit.ly/2U3niaQ

Great talk #ACR20 @anisha_dua re:monitoring in GCA/TAK Remember different distributions in GCA/TAK Slick summary slides with pros/cons of each modality I find myself picking based on clinical context, suspected involvement/extent, and availability #ACRambassador https://t.co/euMGbwirG9

Talk on collaborative research and team building by @rheum_covid leaders @JYazdanyMD & @philipcrobinson Dr. Yazdany with an illustration of what the journey might look like for the ECI phase & beyond #ACR20 #ACRambassador https://t.co/ISNQSrFWws

SELECT-PsA2 group refractory to prior bDMARD therapy UPA - useful oral JAKi option in Psoriatic Arthritis Safety consistent with what we know from RA. More Sfx at 30mg. No clear VTE signal #ACR20 https://t.co/XpprRprugI

Cohort study of 186 AI patients from New York => Among patients hospitalized with COVID-19, individuals with autoimmune disease did not have an increased risk of a composite outcome of intensive care unit admission, intubation, or death. https://t.co/EXGyfrHnjH @jrheum

• Risk of Adverse Outcomes in Hospitalized Patients with Autoimmune Disease and C…

Is It Realistic to Stop Prednisone in Early Rheumatoid Arthritis? A Subanalysis from the BeSt and IMPROVED Studies https://t.co/itrgSeNted #RA #prednisone 18-30% flare ceasing Pred - imi for bridging rather than commence oral! Eular guidelines have a lot to answer for

• Is It Realistic to Stop Prednisone in Early Rheumatoid Arthritis? A Subanalysis…

Integrated Safety of Filgotinib in Patients with Moderately or Severely Active Rheumatoid Arthritis Receiving Treatment for up to 5.5 Years https://t.co/9YNEGXKoAD #RA #filgotinib low vte & low zoster rates

• Integrated Safety of Filgotinib in Patients with Moderately or Severely Active …

Safety Profile of Upadacitinib up to 3 Years of Exposure in Patients with Rheumatoid Arthritis https://t.co/T3cXYlCSRC #RA #Upadacitinib 3 yr safety data

• Safety Profile of Upadacitinib up to 3 Years of Exposure in Patients with Rheum…

Extreme Fatigue in Patients with Systemic Lupus Erythematosus and Neuropsychiatric Symptoms https://t.co/sLGxMwJUhk #SLE #fatigue - fatigue remains a big problem

• Extreme Fatigue in Patients with Systemic Lupus Erythematosus and Neuropsychiat…

Tender non-swollen joints NOT associated with #ultrasound synovitis in DMARD-naïve early #PsoriaticArthritis 👉🏽https://t.co/XcuhlZbpSV by Dr Dubash @LeedsTeamSpA @LeedsBRC #ACR20 #0313 https://t.co/TbpxIy83Qt

• Swollen Joints but Not Tender Joints Are Associated with Ultrasound Power Doppl…

The Prediction of Psoriatic Arthritis Tool (PRESTO) Study – Interim Report https://t.co/zdpk6IvxP0 #PsA # predictors

• The Prediction of Psoriatic Arthritis Tool (PRESTO) Study – Interim Report - AC…

Comparative Efficacy of Guselkumab in Patients with Psoriatic Arthritis: Results from Systematic Literature Review and Network Meta-Analysis https://t.co/hgPDtFRxer #PsA #Guselkumab

• Comparative Efficacy of Guselkumab in Patients with Psoriatic Arthritis: Result…